Gold-Standard Cochrane Review Confirms: Nicotine Vaping Helps More Smokers Quit Than Traditional Nicotine Replacement Therapy

Skip to Content News Archives Economy Energy Oil & Gas Renewables Electric Vehicles Mining Commodities Agriculture Real Estate Mortgages Mortgage Rates Finance Banking Insurance Fintech Cryptocurrency Work Wealth Smart Money Wealth Management Investor Personal Finance Family Finance Retirement Taxes High Net Worth FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials More Innovation Information Technology FP500 Podcasts Small Business Lives Told Tails Told Shopping Financial Post Store Obituaries Place a Notice Advertising Advertising With Us Advertising Solutions Postmedia Ad Manager Sponsorship Requests Classifieds Place a Classifieds ad Working Profile Settings My Subscriptions My Offers Newsletters Customer Service FAQ News Economy Energy Mining Real Estate Finance Work Wealth Investor FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials This advertisement has not loaded yet, but your article continues below.HomeGlobeNewswireThis section is The content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by GlobeNewswire Gold-Standard Cochrane Review Confirms: Nicotine Vaping Helps More Smokers Quit Than Traditional Nicotine Replacement TherapyAuthor of the article:The Canadian Vaping Association calls on Health Canada to align with the world’s most rigorous scientific evidence and better inform smokers that vaping is a less harmful alternative that can help them quitTHIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLYSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.SUBSCRIBE TO UNLOCK MORE ARTICLESSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.REGISTER / SIGN IN TO UNLOCK MORE ARTICLESCreate an account or sign in to continue with your reading experience.Access articles from across Canada with one account.Share your thoughts and join the conversation in the comments.Enjoy additional articles per month.Get email updates from your favourite authors.THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.Create an account or sign in to continue with your reading experience.Access articles from across Canada with one accountShare your thoughts and join the conversation in the commentsEnjoy additional articles per monthGet email updates from your favourite authorsSign In or Create an AccountOttawa, ON, Aug. 31, 2026 (GLOBE NEWSWIRE) — The Canadian Vaping Association welcomed the latest update of the Cochrane living systematic review on electronic cigarettes for smoking cessation, which concludes with high-certainty evidence that nicotine vaping products help more people quit smoking than conventional nicotine replacement therapies (NRT) such as patches and gum. “Nearly 46,000 Canadians die from smoking-related illness every year, and every one of those deaths is preventable,” said Sam Tam, President of the Canadian Vaping Association. “Adult smokers deserve accurate information about less harmful alternatives, and policy should be proportionate to relative risk. That is why the CVA is recommending that Health Canada include vaping harm reduction messaging on cigarette packaging, so Canadians who smoke know there are other proven ways to quit.” Get the latest headlines, breaking news and columns.By signing up you consent to receive the above newsletter from Postmedia Network Inc.A welcome email is on its way. If you don't see it, please check your junk folder.The next issue of Top Stories will soon be in your inbox.We encountered an issue signing you up. Please try againCochrane is widely regarded as the gold standard for systematic reviews and meta-analyses of healthcare evidence. Its living review draws on 80 randomized controlled trials involving nearly 30,000 participants and is continuously updated as new research is published. High-certainty evidence is Cochrane’s strongest rating, reserved for findings unlikely to change with further study. Short-term side effects reported were mild and temporary and faded with continued use. Serious adverse events were rare across every study group, and adverse event rates were similar between nicotine vapes and NRT. Researchers noted that longer-term data beyond two years is still developing, which is a call for continued research. The CVA believes the Cochrane findings carry clear implications for Canadian policy. Adult smokers should have access to accurate, evidence-based information about the relative risks of vaping compared to smoking. Regulations including proposed flavour restrictions, disposable bans, and taxation should be evaluated against their impact on adult smokers seeking to quit, not only on youth prevention goals. At the same time, youth access must continue to be strictly enforced, as the CVA has consistently advocated. The Cochrane findings concern adult smoking cessation and do not diminish the importance of keeping vaping products out of the hands of minors. “We have to strike a balance,” added Sam Tam. “Canadians who cannot successfully quit smoking with nicotine replacement therapy need to know that vaping is an alternative harm reduction tool that can help them quit. Withholding that information does not protect anyone, it keeps people smoking.” The CVA urges Health Canada and provincial governments to review the Cochrane findings and engage with stakeholders on a regulatory framework that maximizes the public health opportunity of tobacco harm reduction while safeguarding youth. This advertisement has not loaded yet.This advertisement has not loaded yet, but your article continues below.The full review, “Electronic cigarettes for smoking cessation,” is available from the Cochrane Library. Source: Lindson N, et al. “Electronic cigarettes for smoking cessation.” Cochrane Database of Systematic Reviews, 2026. cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010216.pub11 Sam Tam The Canadian Vaping Association stam@thecva.org Ashley Bouman The Canadian Vaping Association abouman@thecva.org Notice for the Postmedia NetworkThis website uses cookies to personalize your content (including ads), and allows us to analyze our traffic. Read more about cookies here. By continuing to use our site, you agree to our Terms of Use and Privacy Policy.